Another regional accelerator goes-it alone, capital formation numbers, and more.
VTC For the 14th year, investors, entrepreneurs, strategic corporates meld at FedEx Institute.
Developers studying HudsonAlpha and other innovation centers.
Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
Breast cancer target, regulatory progress and further capital raise action likely.
[updated] Financing spurs Type 2 diabetes, non-alcoholic fatty liver programs
[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders
Scholar and entrepreneur will co-found molecular diagnostics startup in Nashville
Law firm broadens its already sizeable footprint, plants flag in dealing with early-stage ventures
The yet-to-be-operational TNInvestco capital-formation program seems to have kindled fresh interest in key sectors
A supposed transformation of education, plus sustained support from key moneymen seem to have given ALS staying-power
At deal-making summit, investment bankers and others say focus on regulatory pressure for cost-reductions, rather than on next President
While critics sound off and Biotech targets General Assembly, an economy-shaping executive keeps pushing education and innovations
Now, after selling its first FDA-approved product to a close ally, BioMimetic is flush with cash and experience -- and committed to developing biotechnologies in Middle Tennessee.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: